Bestatin therapy of patients with atopic dermatitisTHESTRUP-PEDERSEN, K; CRAMERS, M; KONGSHOLM, H et al.Acta dermato-venereologica. 1983, Vol 63, Num 6, pp 549-552, issn 0001-5555Article

In vivo actions of bestatin-related compounds in relation to their actions in vitroAOYAGI, T; WADA, T; OHUCHI, S et al.Biochemistry international. 1984, Vol 9, Num 5, pp 643-650, issn 0158-5231Article

Successful treatment of murine muscular dystrophy with the protease inhibitor bestatinTSUJI, S; MATSUSHITA, H.Journal of the neurological sciences. 1986, Vol 72, Num 2-3, pp 183-194, issn 0022-510XArticle

DEGRADATION OF ABNORMAL PROTEINS IN INTACT MOUSE RETICULOCYTES: ACCUMULATION OF INTERMEDIATES IN THE PRESENCE OF BESTATINBOTBOL V; SCORNIK OA.1979; PROC. NATION. ACAD. SCI. USA; USA; DA. 1979; VOL. 76; NO 2; PP. 710-713; BIBL. 27 REF.Article

Effect of inhibition of neuropeptidases on the pain threshold of mice and ratsCARENZI, A; FRIGENI, V; REGGIANI, A et al.Neuropharmacology. 1983, Vol 22, Num 11, pp 1315-1319, issn 0028-3908Article

Effect of bestatin and thiorphan on [Met⁵]enkephalin-Arg⁶-Phe⁷-induced analgesiaREGGIANI, A; CARENZI, A; FRIGENI, V et al.European journal of pharmacology. 1984, Vol 105, Num 3-4, pp 361-364, issn 0014-2999Article

EFFECT OF BESTATIN AND MURAMYL-DIPEPTIDE ON MACROPHAGE-BOUND AMINOPEPTIDASEWACHSMUTH ED; WUST B.1981; HOPPE-SEYLER'S Z. PHYSIOL. CHEM.; ISSN 0018-4888; DEU; DA. 1981; VOL. 362; NO 5; PP. 563-568; ABS. GER; BIBL. 15 REF.Article

EFFECT OF BESTATIN ON PROUSE IMMUNE SYSTEM AND EXPERIMENTAL MURINE TUMORSISHIZUKA M; MASUDA T; KANBAYASHI N et al.1980; J. ANTIBIOT.; JPN; DA. 1980; VOL. 33; NO 6; PP. 642-652; BIBL. 12 REF.Article

INTERMEDIATES IN THE DEGRADATION OF ABNORMAL GLOBIN. BESTATIN PERMITS THE ACCUMULATION OF THE SAME PEPTIDES IN CELL-FREE EXTRACTS AS IN INTACT RETICULOCYTESBOT BOL V; SCORNIK OA.1979; J. BIOL. CHEM.; USA; DA. 1979; VOL. 254; NO 22; PP. 11254-11257; BIBL. 24 REF.Article

INHIBITION OF AMINOPEPTIDASE B AND LEUCINE AMINOPEPTIDASE BY BESTATIN AND ITS STEREOISOMER.SUDA H; AOYAGI T; TAKEUCHI T et al.1976; ARCH. BIOCHEM. BIOPHYS.; U.S.A.; DA. 1976; VOL. 177; NO 1; PP. 196-200; BIBL. 16 REF.Article

THE ROLE OF BESTATIN, AN INHIBITOR OF CELL SURFACE PROTEASES, IN THE INTERACTION OF SERUM WITH UNTRANSFORMED CELLS IN CULTUREKOREN R; BERCOVITZ H; UMEZAWA H et al.1981; J. ANTIBIOT.; ISSN 0021-8820; JPN; DA. 1981; VOL. 34; NO 1; PP. 90-94; BIBL. 20 REF.Article

BESTATIN, A NEW IMMUNOMODULATOR, AUGMENTS THE RELEASE OF MITOGENIC FACTORS FROM PHA-STIMULATED HUMAN LYMPHOCYTESBLOMGREN H.1981; BIOMEDICINE; ISSN 0300-0893; FRA; DA. 1981; VOL. 34; NO 4; PP. 188-192; ABS. FRE; BIBL. 30 REF.Article

THE EFFECT OF BESTATIN ON PATIENTS WITH ACUTE AND CHRONIC LEUKEMIA AND MALIGNANT LYMPHOMAARIMORI S; NAGAO T; SHIMIZU Y et al.1980; TOKAI J. EXP. CLIN. MED.; ISSN 0385-0005; JPN; DA. 1980; VOL. 5; NO 1; PP. 63-71; BIBL. 7 REF.Article

Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effortUMEZAWA, H.Reviews of infectious diseases. 1984, Vol 6, Num 3, pp 412-420, issn 0162-0886Article

MITOGENIC EFFECT OF BESTATIN ON LYMPHOCYTESISHIZUKA M; SATO J; SUGIYAMA Y et al.1980; J. ANTIBIOT.; JPN; DA. 1980; VOL. 33; NO 6; PP. 653-662; BIBL. 15 REF.Article

Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatinFRICK, L; WOLFENDEN, R.Biochimica et biophysica acta. 1985, Vol 829, Num 3, pp 311-318, issn 0006-3002Article

Inhibition of aminopeptidases by amastatin and bestatin derivatives: effect of inhibitor structure on slow-binding processesRICH, D. H; BYUNG JO MOON; HARBESON, S et al.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 4, pp 417-422, issn 0022-2623Article

A stereocontrolled synthesis of (-)-bestatin from an acyclic allylamine by iodocyclocarbamationKOBAYASHI, S; ISOBE, T; OHNO, M et al.Tetrahedron letters. 1984, Vol 25, Num 44, pp 5079-5082, issn 0040-4039Article

CHANGES OF BLOOD LYMPHOCYTE POPULATION IN CANCER PATIENTS TREATED WITH BESTATIN, A NEW IMMUNOMODULATOR. A PHASE I STUDYBLOMGREN H; STRENDER LE; EDSMYR F et al.1980; BIOMEDICINE; ISSN 0300-0893; FRA; DA. 1980; VOL. 32; NO 4; PP. 178-185; ABS. FRE; BIBL. 30 REF.Article

Determination of p-hydroxybestatin in human serum by high-performance liquid chromatographty using fluorescence detectionISHIDA, J; KAI, M; OHKURA, Y et al.Journal of chromatography. 1985, Vol 344, pp 267-274, issn 0021-9673Article

Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphanCOQUEREL, A; DUBUC, I; MENARD, J.-F et al.Brain research. 1986, Vol 398, Num 2, pp 386-389, issn 0006-8993Article

Erste Ergebnisse der klinischen Anwendung des Immunstimulans Bestatin (3-Amino-2-Hydroxy-4-Phenylbutyryl-Leucin) bei Patienten mit chronischer Polyarthritis = Premiers résutlats de l'utilisation clinique de l'immunostimulant Bestatine (3-amino-2-hydroxy-4-phénylbutyryl-leucine) chez les malades avec polyarthrite rhumatoïde = First results of clinical use of bestatin in patients with rheumatoid arthritisMESKE, S; VOGT, P; MALY, F.-E et al.Zeitschrift für Rheumatologie (Print). 1985, Vol 44, Num 5, pp 231-236, issn 0340-1855Article

BESTATIN TREATMENT AND THE PERIPHERAL LYMPHOCYTE POPULATION IN CANCER PATIENTSBLOMGREN H; STRENDER LE; EDSMYR F et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 75; PP. 133-138; BIBL. 13 REF.Article

ENHANCEMENT OF DELAYED-TYPE HYPERSENSITIVITY BY BESTATIN. AN INHIBITOR OF AMINOPEPTIDASE B AND LEUCINE AMINOPEPTIDASE.UMEZAWA H; ISHIZUKA M; AOYAGI T et al.1976; J. ANTIBIOT.; JAP.; DA. 1976; VOL. 29; NO 8; PP. 857-859; BIBL. 8 REF.Article

INFLUENCE D'UN INHIBITEUR DES ENZYMES DE SURFACE CELLULAIRE SUR LES FONCTIONS DES LYMPHOCYTES HUMAINS: EFFET D'UN INHIBITEUR DE L'AMINOPEPTIDASE (BESTATINE) SUR LA PRODUCTION D'IMMUNOGLOBULINES INDUITE PAR NITROGENE DE POKEWEED PAR LES LYMPHOCYTES HUMAINSYAMAKURA T; SHIMBO T; YATA J et al.1980; J. JAP. SOC. CANCER THERAPY; JPN; DA. 1980; VOL. 15; NO 1; PP. 32-38; ABS. ENG; BIBL. 22 REF.Article